Impact Biomedical (IBO) Selling, General & Administrative (2022 - 2026)
Impact Biomedical (IBO) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -10.08 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 555.10 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.47 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 493.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 647.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 17.02 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.13 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 101.25 Mn |
| 10 | Impact Biomedical | 47.44 Mn | 50.67 Mn | - | 1.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | -443,000.00 |
| Sep 30, 2025 | 261,000.00 |
| Jun 30, 2025 | 246,000.00 |
| Mar 31, 2025 | 248,000.00 |
| Dec 31, 2024 | -67,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Sep 30, 2023 | 101,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Jun 30, 2022 | 58,000.00 |